首页 > 最新文献

Journal of Gastrointestinal Surgery最新文献

英文 中文
Giant esophageal lipoma 巨大食管脂肪瘤。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101924
Dan-Ni Li , Zhou Li , Zhi-Ren Wang
{"title":"Giant esophageal lipoma","authors":"Dan-Ni Li , Zhou Li , Zhi-Ren Wang","doi":"10.1016/j.gassur.2024.101924","DOIUrl":"10.1016/j.gassur.2024.101924","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101924"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value of radiomics features extracted from baseline computed tomography images in predicting overall survival in patients with nonsurgical pancreatic ductal adenocarcinoma: incorporation of a radiomics score to a multiparametric nomogram to predict 1-year overall survival 从基线 CT 图像中提取的放射组学特征在预测非手术治疗的胰腺导管腺癌患者总生存期中的价值:将放射组学评分纳入多参数命定图以预测一年总生存期。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101882
Seyedeh Panid Madani , Mohammad Mirza-Aghazadeh-Attari , Alireza Mohseni , Shadi Afyouni , Ghazal Zandieh , Haneyeh Shahbazian , Ali Borhani , Iman Yazdani Nia , Daniel Laheru , Timothy M. Pawlik , Ihab R. Kamel

Purpose

This study aimed to determine the value of radiomics features derived from baseline computed tomography (CT) scans and volumetric measurements to predict overall survival (OS) in patients with nonsurgical pancreatic ductal adenocarcinoma (PDAC) treated with a chemotherapy combination regimen of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX).

Methods

In this retrospective single-institution study, 131 patients with nonsurgical PDAC who received FOLFIRINOX neoadjuvant chemotherapy between December 2012 and November 2021 were included. Pretreatment contrast-enhanced CT images were obtained for all patients before inclusion. The primary tumor was contoured by an expert radiologist with 25 years of experience. A total of 845 radiomics features, including first-, second-, and higher-order features, were extracted from the total tumor volume. A feature reduction pipeline was used to reduce the dimensionality of the data. The selected features were used to generate a radiomics score based on the Least Absolute Shrinkage and Selection Operator coefficients. A high-dimensional Cox model was generated on the basis of the radiomics score and other quantitative and semantic imaging findings.

Results

From the 845 radiomics features extracted, 45 were significantly different between the tertiles. The following equation was used to generate a radiomics score: radiomics score = SmallAreaEmphasis (−66.87801 + LargeDependenceEmphasis) − 0.2345916. The radiomics score was significantly different among the 3 groups of the radiomics features (P = .034). The overall difference in survival was significant among the 3 groups (P = .02). The nomogram showed good calibration and showed significant differences among the patients when they were classified as tertiles (P < .00).

Conclusion

Radiomics approaches have the potential to predict OS in nonsurgical patients with PDAC, and the inclusion of semantic imaging findings and pathologic data could further enhance prognostication in patients with PDAC.
目的:确定基线 CT 扫描和容积测量得出的放射组学特征对预测接受 FOLFIRINOX 治疗的非手术胰腺导管腺癌(PDAC)患者总生存期的价值:在这项回顾性单机构研究中,纳入了2012年12月至2021年11月期间接受FOLFIRINOX新辅助化疗的131例非手术治疗PDAC患者。所有患者在纳入前均进行了治疗前对比增强 CT 成像检查。原发肿瘤的轮廓由具有 25 年经验的放射科专家绘制。从肿瘤总体积中总共提取了 845 个放射组学特征,包括一阶、二阶和高阶特征。特征缩减管道用于降低数据的维度。所选特征用于生成基于 LASSO 系数的放射组学评分。根据放射组学评分以及其他定量和语义成像结果生成高维 Cox 模型:结果:在提取的 845 个放射组学特征中,有 45 个特征在三元组之间存在显著差异。放射组学评分公式如下:=小面积强调⁎-66.87801+大依赖性强调⁎-0.2345916。放射组学评分在三组放射组学特征之间存在显著差异(P = 0.034)。三组的总生存率差异显著(P = 0.02)。提名图显示出良好的校准性,并在将患者分为三等分时显示出显著差异(P 结论:放射组学方法具有预测非手术治疗的胰腺导管腺癌患者总生存期的潜力,纳入语义成像结果和病理数据可进一步提高 PDAC 患者的预后。
{"title":"Value of radiomics features extracted from baseline computed tomography images in predicting overall survival in patients with nonsurgical pancreatic ductal adenocarcinoma: incorporation of a radiomics score to a multiparametric nomogram to predict 1-year overall survival","authors":"Seyedeh Panid Madani ,&nbsp;Mohammad Mirza-Aghazadeh-Attari ,&nbsp;Alireza Mohseni ,&nbsp;Shadi Afyouni ,&nbsp;Ghazal Zandieh ,&nbsp;Haneyeh Shahbazian ,&nbsp;Ali Borhani ,&nbsp;Iman Yazdani Nia ,&nbsp;Daniel Laheru ,&nbsp;Timothy M. Pawlik ,&nbsp;Ihab R. Kamel","doi":"10.1016/j.gassur.2024.101882","DOIUrl":"10.1016/j.gassur.2024.101882","url":null,"abstract":"<div><h3>Purpose</h3><div>This study aimed to determine the value of radiomics features derived from baseline computed tomography (CT) scans and volumetric measurements to predict overall survival (OS) in patients with nonsurgical pancreatic ductal adenocarcinoma (PDAC) treated with a chemotherapy combination regimen of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX).</div></div><div><h3>Methods</h3><div>In this retrospective single-institution study, 131 patients with nonsurgical PDAC who received FOLFIRINOX neoadjuvant chemotherapy between December 2012 and November 2021 were included. Pretreatment contrast-enhanced CT images were obtained for all patients before inclusion. The primary tumor was contoured by an expert radiologist with 25 years of experience. A total of 845 radiomics features, including first-, second-, and higher-order features, were extracted from the total tumor volume. A feature reduction pipeline was used to reduce the dimensionality of the data. The selected features were used to generate a radiomics score based on the Least Absolute Shrinkage and Selection Operator coefficients. A high-dimensional Cox model was generated on the basis of the radiomics score and other quantitative and semantic imaging findings.</div></div><div><h3>Results</h3><div>From the 845 radiomics features extracted, 45 were significantly different between the tertiles. The following equation was used to generate a radiomics score: radiomics score = SmallAreaEmphasis (−66.87801 + LargeDependenceEmphasis) − 0.2345916. The radiomics score was significantly different among the 3 groups of the radiomics features (<em>P</em> = .034). The overall difference in survival was significant among the 3 groups (<em>P</em> = .02). The nomogram showed good calibration and showed significant differences among the patients when they were classified as tertiles (<em>P</em> &lt; .00).</div></div><div><h3>Conclusion</h3><div>Radiomics approaches have the potential to predict OS in nonsurgical patients with PDAC, and the inclusion of semantic imaging findings and pathologic data could further enhance prognostication in patients with PDAC.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101882"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metachronous gastric metastasis from clear cell renal cell carcinoma presenting with gastrointestinal bleeding 表现为消化道出血的透明细胞肾细胞癌并发胃转移。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101891
Abdeali Saif A. Kaderi, Amandeep Arora, Manish Suresh Bhandare
{"title":"Metachronous gastric metastasis from clear cell renal cell carcinoma presenting with gastrointestinal bleeding","authors":"Abdeali Saif A. Kaderi,&nbsp;Amandeep Arora,&nbsp;Manish Suresh Bhandare","doi":"10.1016/j.gassur.2024.101891","DOIUrl":"10.1016/j.gassur.2024.101891","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101891"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142687192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GI Surgery Summit white paper: recruiting and training the next generation of surgeons 消化道外科峰会白皮书:招聘和培训下一代外科医生。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101896
Jenny H. Chang , Kelsey Romatoski , Madeline B. Torres , Cyrus John Sholevar , Brenessa Lindeman , Cameron Gaskill , Callisia N. Clark , Flavio Rocha , Taylor S. Riall , Jennifer F. Tseng , Jennifer S. Davids , Timothy M. Pawlik , R. Matthew Walsh

Background

There is an ongoing debate on surgical training and its evolution to meet the demands of a complex and changing healthcare environment.

Methods

A GI Surgery Summit was held in January 2024 that included prominent leaders and rising talents from the Society for Surgery of the Alimentary Tract, Society of Surgical Oncology, Association for Academic Surgery, and Society of University Surgeons. This meeting was held to address the multifaceted current and future challenges of surgery.

Results

This paper addresses the topic of recruitment and training of the next generation of surgeons in the United States and abroad and reflects a collective focus on surgical education to ensure the delivery of high-quality care in an increasingly sophisticated medical and surgical landscape.

Conclusion

The discussions and recommendations from the 2024 GI Surgery Summit underscore the crucial need to support diversity, embrace innovative educational frameworks, build a robust global surgical workforce, and foster a culture of wellness and support. Focusing on these key areas ensures that the future leaders of surgery are not only skilled and knowledgeable but also resilient and compassionate, ready to meet the evolving challenges of the healthcare landscape.
背景:关于外科培训及其演变以满足复杂多变的医疗环境需求的讨论一直在进行:2024年1月举行的消化道外科峰会包括来自消化道外科学会(SSAT)、肿瘤外科学会(SSO)、学术外科学会(AAS)和大学外科医生学会(SUS)的杰出领袖和后起之秀。召开此次会议的目的是应对外科当前和未来面临的多方面挑战:结论:2024 年消化道外科峰会的讨论和建议强调了支持多样性、接受创新教育框架、建立强大的全球外科人才队伍以及培养健康和支持文化的迫切需要。通过关注这些关键领域,我们可以确保未来的外科领导者不仅技术精湛、知识渊博,而且坚韧不拔、富有同情心,能够随时应对医疗保健领域不断变化的挑战。
{"title":"GI Surgery Summit white paper: recruiting and training the next generation of surgeons","authors":"Jenny H. Chang ,&nbsp;Kelsey Romatoski ,&nbsp;Madeline B. Torres ,&nbsp;Cyrus John Sholevar ,&nbsp;Brenessa Lindeman ,&nbsp;Cameron Gaskill ,&nbsp;Callisia N. Clark ,&nbsp;Flavio Rocha ,&nbsp;Taylor S. Riall ,&nbsp;Jennifer F. Tseng ,&nbsp;Jennifer S. Davids ,&nbsp;Timothy M. Pawlik ,&nbsp;R. Matthew Walsh","doi":"10.1016/j.gassur.2024.101896","DOIUrl":"10.1016/j.gassur.2024.101896","url":null,"abstract":"<div><h3>Background</h3><div>There is an ongoing debate on surgical training and its evolution to meet the demands of a complex and changing healthcare environment.</div></div><div><h3>Methods</h3><div>A GI Surgery Summit was held in January 2024 that included prominent leaders and rising talents from the Society for Surgery of the Alimentary Tract, Society of Surgical Oncology, Association for Academic Surgery, and Society of University Surgeons. This meeting was held to address the multifaceted current and future challenges of surgery.</div></div><div><h3>Results</h3><div>This paper addresses the topic of recruitment and training of the next generation of surgeons in the United States and abroad and reflects a collective focus on surgical education to ensure the delivery of high-quality care in an increasingly sophisticated medical and surgical landscape.</div></div><div><h3>Conclusion</h3><div>The discussions and recommendations from the 2024 GI Surgery Summit underscore the crucial need to support diversity, embrace innovative educational frameworks, build a robust global surgical workforce, and foster a culture of wellness and support. Focusing on these key areas ensures that the future leaders of surgery are not only skilled and knowledgeable but also resilient and compassionate, ready to meet the evolving challenges of the healthcare landscape.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101896"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142695708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Change and predictors of body composition after gastrectomy for gastric cancer during first postoperative year 胃癌胃切除术后第一年身体成分的变化和预测因素
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101931
Tomohiro Osaki , Tomoyuki Matsunaga , Masahiro Makinoya , Shota Shimizu , Yuji Shishido , Kozo Miyatani , Ayumi Tsuda , Kanenori Endo , Keigo Ashida , Shigeru Tatebe , Yoshiyuki Fujiwara

Purpose

After gastrectomy for gastric cancer, patients often lose significant body weight because of decreased caloric intake and nutrient absorption. Body weight typically requires approximately 1 year to stabilize. This study aimed to examine the changes and predictors of body composition during the first postoperative year.

Methods

A total of 230 patients underwent radical gastrectomy for stage I to III gastric cancers. Body composition was measured using bioelectrical impedance analysis, and changes were analyzed over 1 year. Multiple regression analysis was used to identify predictors of body composition changes.

Results

Body composition changes and significant body weight and body fat mass reductions occurred primarily within the first 6 months postoperatively. Skeletal muscle mass initially decreased but improved after 6 months without significant changes related to adjuvant chemotherapy. Increased edema was observed at 6 and 12 months postoperatively in patients after total gastrectomy and adjuvant chemotherapy. Gastrectomy type and body mass index significantly affected postoperative body weight changes. In addition, gastrectomy type was associated with changes in skeletal muscle mass and bone mineral content. Adjuvant chemotherapy significantly affected the whole-body phase angle at 6 and 12 months.

Conclusion

Our findings emphasized the initial significant reductions postoperatively and subsequent adjustments over time and elucidated the complex interplay between surgical techniques, adjuvant treatment, and patient characteristics and midterm changes in body composition.
目的:胃癌患者行胃切除术后,由于热量摄入和营养吸收减少,体重明显下降。体重通常需要大约1年才能稳定下来。本研究旨在探讨术后第一年与身体组成相关的变化和预测因素。方法:230例I-III期胃癌患者行根治性胃切除术。采用生物电阻抗分析法测量身体成分,并分析1年内的变化。采用多元回归分析确定身体成分变化的预测因素。结果:体成分的改变和显著的体重和体脂量的减少主要发生在术后的前6个月内。骨骼肌质量最初下降,但在6个月后有所改善,没有与辅助化疗相关的显著变化。全胃切除术和辅助化疗后患者术后6个月和12个月水肿增加。胃切除术类型和体重指数显著影响术后体重变化。胃切除术类型也与骨骼肌量和骨矿物质含量的变化有关。辅助化疗对6个月和12个月的全身相角有显著影响。结论:这些发现强调了术后最初的显著降低和随后的调整,并阐明了手术技术、辅助治疗、患者特征和中期身体成分变化之间复杂的相互作用。
{"title":"Change and predictors of body composition after gastrectomy for gastric cancer during first postoperative year","authors":"Tomohiro Osaki ,&nbsp;Tomoyuki Matsunaga ,&nbsp;Masahiro Makinoya ,&nbsp;Shota Shimizu ,&nbsp;Yuji Shishido ,&nbsp;Kozo Miyatani ,&nbsp;Ayumi Tsuda ,&nbsp;Kanenori Endo ,&nbsp;Keigo Ashida ,&nbsp;Shigeru Tatebe ,&nbsp;Yoshiyuki Fujiwara","doi":"10.1016/j.gassur.2024.101931","DOIUrl":"10.1016/j.gassur.2024.101931","url":null,"abstract":"<div><h3>Purpose</h3><div>After gastrectomy for gastric cancer, patients often lose significant body weight because of decreased caloric intake and nutrient absorption. Body weight typically requires approximately 1 year to stabilize. This study aimed to examine the changes and predictors of body composition during the first postoperative year.</div></div><div><h3>Methods</h3><div>A total of 230 patients underwent radical gastrectomy for stage I to III gastric cancers. Body composition was measured using bioelectrical impedance analysis, and changes were analyzed over 1 year. Multiple regression analysis was used to identify predictors of body composition changes.</div></div><div><h3>Results</h3><div>Body composition changes and significant body weight and body fat mass reductions occurred primarily within the first 6 months postoperatively. Skeletal muscle mass initially decreased but improved after 6 months without significant changes related to adjuvant chemotherapy. Increased edema was observed at 6 and 12 months postoperatively in patients after total gastrectomy and adjuvant chemotherapy. Gastrectomy type and body mass index significantly affected postoperative body weight changes. In addition, gastrectomy type was associated with changes in skeletal muscle mass and bone mineral content. Adjuvant chemotherapy significantly affected the whole-body phase angle at 6 and 12 months.</div></div><div><h3>Conclusion</h3><div>Our findings emphasized the initial significant reductions postoperatively and subsequent adjustments over time and elucidated the complex interplay between surgical techniques, adjuvant treatment, and patient characteristics and midterm changes in body composition.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101931"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142824225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric metastasis from Merkel cell carcinoma 梅克尔细胞癌的胃转移。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101925
Juliana Maria Napoli, Felipe Higuera, Fernando Gabriel Wright
{"title":"Gastric metastasis from Merkel cell carcinoma","authors":"Juliana Maria Napoli,&nbsp;Felipe Higuera,&nbsp;Fernando Gabriel Wright","doi":"10.1016/j.gassur.2024.101925","DOIUrl":"10.1016/j.gassur.2024.101925","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101925"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A national perspective on palliative interventions for malignant gastric outlet obstruction 恶性胃出口梗阻姑息干预的国家视角。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101884
Ayesha P. Ng, Joseph E. Hadaya, Yas Sanaiha, Nikhil L. Chervu, Mark D. Girgis, Peyman Benharash

Background

Of note, 15% to 20% of patients with duodenal or periampullary malignancies develop gastric outlet obstruction (GOO). Although small randomized trials have reported more rapid recovery and shorter hospital stay with endoscopic stenting (ES), limited studies have evaluated outcomes at a national level. The current study characterized short-term clinical and financial outcomes associated with gastrojejunostomy (GJ) vs ES in malignant GOO.

Methods

Adults with malignant GOO treated with ES or GJ were identified in the 2016–2020 Nationwide Readmissions Database. Entropy balancing was used to balance covariates between groups, and multivariate regression was used to evaluate the association between GJ or ES and in-hospital mortality, total parenteral nutrition (TPN) use, complications, length of stay (LOS), costs, and 90-day readmission.

Results

Of 8186 patients with GOO, 5603 (68.4%) underwent ES, and 2583 (31.6%) underwent GJ. The cohorts were similar in age, female/male sex, and comorbidities. However, patients who underwent GJ were more commonly frail. After risk adjustment, mortality, composite complications, and 90-day readmission were comparable between patients who underwent GJ and those who underwent ES. GJ was associated with greater odds of blood transfusion (adjusted odds ratio [AOR], 1.74; 95% CI, 1.37–2.21) and postoperative TPN use (AOR, 3.76; 95% CI, 2.64–5.35). Furthermore, patients who underwent GJ experienced a significant increment of >$15,800 in costs and >6.9 days in LOS. In subgroup analysis of patients with metastatic disease, mortality, complications, and readmission remained comparable among palliation strategies.

Conclusion

ES seems to yield comparable short-term morbidity and mortality relative to GJ with significant cost reduction. Increasing access to endoscopic technology and regionalizing care to high-volume centers may help improve outcomes for patients with malignant GOO.
背景:大约 15-20% 的十二指肠或胰腺周围恶性肿瘤患者会出现 GOO。虽然有小型随机试验报告称 ES 可使患者恢复更快、住院时间更短,但在全国范围内对结果进行评估的研究却很有限。本研究对恶性胃出口梗阻(GOO)的胃空肠吻合术(GJ)与内镜支架植入术(ES)的短期临床和经济效果进行了评估:从2016-2020年全国再入院数据库中识别出接受ES或GJ治疗的恶性GOO成人。采用熵平衡法平衡各组间的协变量,并采用多变量回归法评估GJ或ES与院内死亡率、全肠外营养(TPN)使用、并发症、住院时间(LOS)、费用和90天再入院之间的关系:在8186名GOO患者中,68.4%接受了ES治疗,31.6%接受了GJ治疗。两组患者的年龄、性别和合并症相似,而 GJ 患者更常见于体弱者。经过风险调整后,GJ 和 ES 的死亡率、综合并发症和 90 天再入院率相当。GJ 患者输血(AOR 1.74 [95% CI [1.37-2.21])和术后使用 TPN(AOR 3.76 [95% CI 2.64-5.35])的几率更高。此外,GJ 患者的费用显著增加了 15,800 美元,LOS 增加了 6.9 天。对患有转移性疾病的患者进行亚组分析后发现,不同缓解策略的死亡率、并发症和再入院率仍然相当:结论:与 GJ 相比,ES 的短期发病率和死亡率与 GJ 相当,且能显著降低成本。增加使用内窥镜技术的机会,并将医疗服务区域化,使其集中在高流量中心,可能有助于改善恶性 GOO 患者的治疗效果。
{"title":"A national perspective on palliative interventions for malignant gastric outlet obstruction","authors":"Ayesha P. Ng,&nbsp;Joseph E. Hadaya,&nbsp;Yas Sanaiha,&nbsp;Nikhil L. Chervu,&nbsp;Mark D. Girgis,&nbsp;Peyman Benharash","doi":"10.1016/j.gassur.2024.101884","DOIUrl":"10.1016/j.gassur.2024.101884","url":null,"abstract":"<div><h3>Background</h3><div>Of note, 15% to 20% of patients with duodenal or periampullary malignancies develop gastric outlet obstruction (GOO). Although small randomized trials have reported more rapid recovery and shorter hospital stay with endoscopic stenting (ES), limited studies have evaluated outcomes at a national level. The current study characterized short-term clinical and financial outcomes associated with gastrojejunostomy (GJ) vs ES in malignant GOO.</div></div><div><h3>Methods</h3><div>Adults with malignant GOO treated with ES or GJ were identified in the 2016–2020 Nationwide Readmissions Database. Entropy balancing was used to balance covariates between groups, and multivariate regression was used to evaluate the association between GJ or ES and in-hospital mortality, total parenteral nutrition (TPN) use, complications, length of stay (LOS), costs, and 90-day readmission.</div></div><div><h3>Results</h3><div>Of 8186 patients with GOO, 5603 (68.4%) underwent ES, and 2583 (31.6%) underwent GJ. The cohorts were similar in age, female/male sex, and comorbidities. However, patients who underwent GJ were more commonly frail. After risk adjustment, mortality, composite complications, and 90-day readmission were comparable between patients who underwent GJ and those who underwent ES. GJ was associated with greater odds of blood transfusion (adjusted odds ratio [AOR], 1.74; 95% CI, 1.37–2.21) and postoperative TPN use (AOR, 3.76; 95% CI, 2.64–5.35). Furthermore, patients who underwent GJ experienced a significant increment of &gt;$15,800 in costs and &gt;6.9 days in LOS. In subgroup analysis of patients with metastatic disease, mortality, complications, and readmission remained comparable among palliation strategies.</div></div><div><h3>Conclusion</h3><div>ES seems to yield comparable short-term morbidity and mortality relative to GJ with significant cost reduction. Increasing access to endoscopic technology and regionalizing care to high-volume centers may help improve outcomes for patients with malignant GOO.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101884"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142639045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between sex-specific criteria for visceral obesity and surgical site infection after gastrectomy 胃切除术后内脏肥胖的性别特异性标准与手术部位感染的关系。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101919
Shinichiro Shiomi , Wataru Gonoi , Kotaro Sugawara , Satoru Taguchi , Shouhei Hanaoka , Mariko Kurokawa , Nobuhiko Akamatsu , Shohei Inui , Koichi Yagi , Haruki Kume , Osamu Abe , Yasuyuki Seto

Background

High visceral fat area (VFA), estimated by computed tomography (CT), is reportedly associated with surgical site infection (SSI) in patients who undergo gastrectomy for gastric cancer (GC). Given that fat distributions vary markedly according to sex, sex-specific definitions of visceral obesity should be applied. This study investigated the optimal sex-specific thresholds for VFA at the L3 level to assess the risk of SSI after gastrectomy.

Methods

This study included 828 patients (564 males and 264 females) who underwent curative gastrectomy. Intra-abdominal or incisional infectious complications with Clavien-Dindo scores ≥ 2 were defined as SSIs. Receiver operating characteristic (ROC) analyses were used to determine the optimal sex-specific VFA cutoffs to extract patients with obesity who are at risk of developing SSI. In addition, logistic regression analyses were performed, and the corrected Akaike information criterion (AICc) was calculated to compare the capability to evaluate the possibility of SSI of our sex-specific VFA-based criteria vs the conventional VFA-based or body mass index (BMI)-based criterion.

Results

SSI developed in 59 males and 16 females. Optimal VFA thresholds were 119.3 cm2 for males and 57.2 cm2 for females. Multivariate analyses revealed visceral obesity, as defined by the sex-specific criteria, to be an independent risk factor for SSI (odds ratio, 2.74; 95% CI, 1.62–4.66; P <.01). The logistic regression model with our sex-specific criteria yielded a better AICc (456.4) than the conventional (461.8) or BMI-based (467.0) criterion for obesity.

Conclusion

Sex-specific criteria can enhance the capability of VFA to assess the risk of SSI after gastrectomy, compared with the non–sex-specific criterion.
背景:据报道,通过计算机断层扫描(CT)估计的高内脏脂肪面积(VFA)与胃癌(GC)胃切除术患者的手术部位感染(SSI)有关。鉴于脂肪分布因性别而有显著差异,应采用针对性别的内脏性肥胖定义。我们研究了L3水平VFA的最佳性别特异性阈值,以评估胃切除术后SSI的风险。方法:对行根治性胃切除术的828例患者(男564例,女264例)进行研究。Clavien Dindo评分≥2的腹腔内或切口感染并发症被定义为ssi。受试者工作特征(ROC)分析用于确定提取易发生SSI的肥胖患者的最佳性别特异性VFA截止值。我们进行了逻辑回归分析,并计算了修正后的Akaike信息标准(AICc),以比较我们基于性别的基于vfa的标准与传统的基于vfa或基于bmi的标准评估SSI可能性的能力。结果:男性59例,女性16例。最佳VFA阈值为男性119.3 cm2,女性57.2 cm2。多变量分析显示,根据性别特异性标准定义的内脏肥胖是SSI的独立危险因素(优势比:2.74;95%置信区间:1.62-4.66;P < 0.01)。采用我们的性别特异性标准的logistic回归模型得出的AICc(456.4)优于采用传统标准(461.8)或基于bmi(467.0)的肥胖标准。结论:与非性别标准相比,性别特异性标准可提高VFA评估胃切除术后SSI风险的能力。
{"title":"Association between sex-specific criteria for visceral obesity and surgical site infection after gastrectomy","authors":"Shinichiro Shiomi ,&nbsp;Wataru Gonoi ,&nbsp;Kotaro Sugawara ,&nbsp;Satoru Taguchi ,&nbsp;Shouhei Hanaoka ,&nbsp;Mariko Kurokawa ,&nbsp;Nobuhiko Akamatsu ,&nbsp;Shohei Inui ,&nbsp;Koichi Yagi ,&nbsp;Haruki Kume ,&nbsp;Osamu Abe ,&nbsp;Yasuyuki Seto","doi":"10.1016/j.gassur.2024.101919","DOIUrl":"10.1016/j.gassur.2024.101919","url":null,"abstract":"<div><h3>Background</h3><div>High visceral fat area (VFA), estimated by computed tomography (CT), is reportedly associated with surgical site infection (SSI) in patients who undergo gastrectomy for gastric cancer (GC). Given that fat distributions vary markedly according to sex, sex-specific definitions of visceral obesity should be applied. This study investigated the optimal sex-specific thresholds for VFA at the L3 level to assess the risk of SSI after gastrectomy.</div></div><div><h3>Methods</h3><div>This study included 828 patients (564 males and 264 females) who underwent curative gastrectomy. Intra-abdominal or incisional infectious complications with Clavien-Dindo scores ≥ 2 were defined as SSIs. Receiver operating characteristic (ROC) analyses were used to determine the optimal sex-specific VFA cutoffs to extract patients with obesity who are at risk of developing SSI. In addition, logistic regression analyses were performed, and the corrected Akaike information criterion (AICc) was calculated to compare the capability to evaluate the possibility of SSI of our sex-specific VFA-based criteria vs the conventional VFA-based or body mass index (BMI)-based criterion.</div></div><div><h3>Results</h3><div>SSI developed in 59 males and 16 females. Optimal VFA thresholds were 119.3 cm<sup>2</sup> for males and 57.2 cm<sup>2</sup> for females. Multivariate analyses revealed visceral obesity, as defined by the sex-specific criteria, to be an independent risk factor for SSI (odds ratio, 2.74; 95% CI, 1.62–4.66; <em>P</em> &lt;.01). The logistic regression model with our sex-specific criteria yielded a better AICc (456.4) than the conventional (461.8) or BMI-based (467.0) criterion for obesity.</div></div><div><h3>Conclusion</h3><div>Sex-specific criteria can enhance the capability of VFA to assess the risk of SSI after gastrectomy, compared with the non–sex-specific criterion.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101919"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142769554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic surgery for gastric gastrointestinal stromal tumor in the age of Enhanced Recovery After Surgery ERAS时代胃间质瘤的腹腔镜手术。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101920
Mohammad S. Farooq , Valentina Mattfeld , Neha Shafique , Gracia M. Vargas , John T. Miura , Giorgos C. Karakousis
{"title":"Laparoscopic surgery for gastric gastrointestinal stromal tumor in the age of Enhanced Recovery After Surgery","authors":"Mohammad S. Farooq ,&nbsp;Valentina Mattfeld ,&nbsp;Neha Shafique ,&nbsp;Gracia M. Vargas ,&nbsp;John T. Miura ,&nbsp;Giorgos C. Karakousis","doi":"10.1016/j.gassur.2024.101920","DOIUrl":"10.1016/j.gassur.2024.101920","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101920"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142780342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delta-integrated relaxation pressures as a new high-resolution manometry metric to predict the positive outcome of laparoscopic Heller-Dor in patients with achalasia δ-irp作为一种新的高分辨率测压指标,可预测贲门失弛缓症患者腹腔镜heller-dor术的疗效。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101928
Andrea Costantini , Matteo Pittacolo , Giulia Nezi , Giovanni Capovilla , Mario Costantini , Arianna Vittori , Matteo Santangelo , Luca Provenzano , Loredana Nicoletti , Francesca Forattini , Lucia Moletta , Michele Valmasoni , Edoardo V. Savarino , Renato Salvador

Background

There is no consensus on the definition of failure after treatment in patients with achalasia. The Eckardt score is used to define clinical outcomes. However, objective metrics are lacking. This study aimed to identify whether any high-resolution manometry (HRM) parameters may be useful in predicting a positive outcome after laparoscopic Heller-Dor (LHD).

Methods

Patients who underwent LHD between 2012 and 2022 were enrolled. The patients were divided according to the outcome: the success group (SG) and the failure group (FG). In addition to the common HRM parameters, we measured the difference between pre- and postoperative integrated relaxation pressures (∆-IRPs). A receiver operating characteristic (ROC) curve analysis was performed to assess the accuracy of each HRM parameter.

Results

Of note, 336 patients (92.3%) were classified in the SG, and 28 patients (7.7%) were classified in the FG. No difference was found in terms of manometric types, symptom duration, and history of previous treatments. Preoperative lower esophageal sphincter (LES) pressure and IRP were higher in the SG than in the FG (41 vs 35 mm Hg [P =.03] and 33 vs 26 mm Hg [P =.002], respectively). The postoperative LES metrics were similar between the 2 groups, except for the ∆-IRP that was higher in the SG (23 mm Hg [IQR, 15–31]) than in the FG (14 mm Hg [IQR, 9–17]) (P =.0002). In the univariate analysis, age, LES preoperative pressure, IRP, and ∆-IRP were factors able to predict a positive clinical outcome. In the multivariate analysis, the ∆-IRP was the only parameter independently related to clinical success (odds ratio, 0.94; 5%–95% CI, 0.89–0.99). The ROC curve for the ∆-IRP showed an area under the curve of 0.71, with a threshold value set at 16.5 mm Hg (sensibility of 71% and specificity of 70%).

Conclusion

Our data showed that the ∆-IRP with a threshold of 16.5 mm Hg could represent a new objective tool for predicting the long-term positive outcome of LHD in patients with esophageal achalasia.
对贲门失弛缓症患者治疗后失败的定义尚无共识。Eckardt评分(ES)用于定义临床结果,但缺乏客观指标。本研究的目的是确定是否有任何高分辨率测压(HRM)参数可能有助于预测腹腔镜Heller-Dor (LHD)后的阳性结果。方法:纳入2012-2022年间接受LHD的患者。根据治疗结果分为成功组(SG)和失败组(FG)。除了常见的HRM参数外,我们还测量了术前和术后综合松弛压力(∆- irp)之间的差异。应用ROC曲线分析来评估每个HRM参数的准确性。结果:336例患者(92.3%)分为SG组,28例(7.7%)分为FG组。两组在测压类型、症状持续时间和既往治疗史方面均无差异;术前食管下括约肌(LES)压力和IRP在SG组高于FG组(41 vs 35mmHg, p=0.03和33 vs 26mmHg, p=0.002)。两组术后LES指标相似,但SG组(23mmHg, IQR:15-31)的∆-IRP高于FG组(14mmHg, IQR:9-17, p=0.0002)。在单变量分析中,年龄、LES术前压力、IRP和∆-IRP是能够预测阳性临床结果的因素。在多变量分析中,∆-IRP是唯一与临床成功独立相关的参数(p)结论:我们的数据表明,阈值为16.5mmHg的∆-IRP可以作为预测食管贲门失弛缓症患者LHD长期阳性结果的一种新的客观工具。
{"title":"Delta-integrated relaxation pressures as a new high-resolution manometry metric to predict the positive outcome of laparoscopic Heller-Dor in patients with achalasia","authors":"Andrea Costantini ,&nbsp;Matteo Pittacolo ,&nbsp;Giulia Nezi ,&nbsp;Giovanni Capovilla ,&nbsp;Mario Costantini ,&nbsp;Arianna Vittori ,&nbsp;Matteo Santangelo ,&nbsp;Luca Provenzano ,&nbsp;Loredana Nicoletti ,&nbsp;Francesca Forattini ,&nbsp;Lucia Moletta ,&nbsp;Michele Valmasoni ,&nbsp;Edoardo V. Savarino ,&nbsp;Renato Salvador","doi":"10.1016/j.gassur.2024.101928","DOIUrl":"10.1016/j.gassur.2024.101928","url":null,"abstract":"<div><h3>Background</h3><div>There is no consensus on the definition of failure after treatment in patients with achalasia. The Eckardt score is used to define clinical outcomes. However, objective metrics are lacking. This study aimed to identify whether any high-resolution manometry (HRM) parameters may be useful in predicting a positive outcome after laparoscopic Heller-Dor (LHD).</div></div><div><h3>Methods</h3><div>Patients who underwent LHD between 2012 and 2022 were enrolled. The patients were divided according to the outcome: the success group (SG) and the failure group (FG). In addition to the common HRM parameters, we measured the difference between pre- and postoperative integrated relaxation pressures (∆-IRPs). A receiver operating characteristic (ROC) curve analysis was performed to assess the accuracy of each HRM parameter.</div></div><div><h3>Results</h3><div>Of note, 336 patients (92.3%) were classified in the SG, and 28 patients (7.7%) were classified in the FG. No difference was found in terms of manometric types, symptom duration, and history of previous treatments. Preoperative lower esophageal sphincter (LES) pressure and IRP were higher in the SG than in the FG (41 vs 35 mm Hg [<em>P</em> =.03] and 33 vs 26 mm Hg [<em>P</em> =.002], respectively). The postoperative LES metrics were similar between the 2 groups, except for the ∆-IRP that was higher in the SG (23 mm Hg [IQR, 15–31]) than in the FG (14 mm Hg [IQR, 9–17]) (<em>P</em> =.0002). In the univariate analysis, age, LES preoperative pressure, IRP, and ∆-IRP were factors able to predict a positive clinical outcome. In the multivariate analysis, the ∆-IRP was the only parameter independently related to clinical success (odds ratio, 0.94; 5%–95% CI, 0.89–0.99). The ROC curve for the ∆-IRP showed an area under the curve of 0.71, with a threshold value set at 16.5 mm Hg (sensibility of 71% and specificity of 70%).</div></div><div><h3>Conclusion</h3><div>Our data showed that the ∆-IRP with a threshold of 16.5 mm Hg could represent a new objective tool for predicting the long-term positive outcome of LHD in patients with esophageal achalasia.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101928"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142824228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Gastrointestinal Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1